BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35896219)

  • 1. Significance of Intraperitoneal-free
    Kaku H; Aoyagi K; Sudo T; Tanaka Y; Minami T; Isobe T; Kizaki J; Umetani Y; Murakami N; Fujita F; Akagi Y
    Anticancer Res; 2022 Aug; 42(8):4003-4010. PubMed ID: 35896219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
    Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
    Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
    Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
    Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.
    Marutsuka T; Shimada S; Shiomori K; Hayashi N; Yagi Y; Yamane T; Ogawa M
    Clin Cancer Res; 2003 Feb; 9(2):678-85. PubMed ID: 12576435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer.
    Takata A; Kurokawa Y; Fujiwara Y; Nakamura Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    World J Surg; 2014 May; 38(5):1107-11. PubMed ID: 24305936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of the quantitative carcinoembryonic antigen and cytokeratin 20 mRNA detection in peritoneal washes to predict peritoneal recurrence in gastric carcinoma patients.
    Tamura N; Iinuma H; Takada T
    Oncol Rep; 2007 Mar; 17(3):667-72. PubMed ID: 17273749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer.
    Tokuda K; Natsugoe S; Nakajo A; Miyazono F; Ishigami S; Hokita S; Takao S; Eizuru Y; Aikou T
    Int J Mol Med; 2003 Jan; 11(1):79-84. PubMed ID: 12469223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer.
    Sugita Y; Fujiwara Y; Taniguchi H; Mori T; Ishii T; Niwa H; Okada Y; Takiguchi S; Yasuda T; Yano M; Monden M
    Int J Oncol; 2003 Nov; 23(5):1419-23. PubMed ID: 14532985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospective, multicenter study.
    Fujiwara Y; Okada K; Hanada H; Tamura S; Kimura Y; Fujita J; Imamura H; Kishi K; Yano M; Miki H; Okada K; Takayama O; Aoki T; Mori M; Doki Y
    Surgery; 2014 Mar; 155(3):417-23. PubMed ID: 24439740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure.
    Fujii S; Kitayama J; Kaisaki S; Sasaki S; Seto Y; Tominaga O; Tsuno N; Umetani N; Yokota H; Kitamura K; Tsuruo T; Nagawa H
    J Exp Clin Cancer Res; 2002 Dec; 21(4):547-53. PubMed ID: 12636101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of carcinoembryonic antigen messenger RNA level in peritoneal lavage fluids measured by transcription-reverse transcription concerted reaction for advanced gastric cancer in laparoscopic surgery.
    Fujita K; Omori T; Hara H; Shinno N; Yamamoto M; Aoyama Y; Sugimura K; Kanemura T; Takeoka T; Yasui M; Matsuda C; Takahashi H; Wada H; Nishimura J; Haraguchi N; Hasegawa S; Nakai N; Asukai K; Mukai Y; Miyata H; Ohue M; Sakon M
    Surg Endosc; 2022 Apr; 36(4):2514-2523. PubMed ID: 33999253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Detection of Messenger RNA for Carcinoembryonic Antigen and Cytokeratin 20 in Peritoneal Washing Fluid in Patients with Advanced Gastric Cancer.
    Kim YJ; Chung WC; Choi S; Jung YD; Lee J; Chae SY; Jun KH; Chin HM
    Korean J Gastroenterol; 2017 Apr; 69(4):220-225. PubMed ID: 28449423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma.
    Okada K; Fujiwara Y; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Takahashi T; Mori M; Doki Y
    J Surg Oncol; 2012 Jun; 105(8):780-5. PubMed ID: 22012575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial.
    Tamura S; Fujiwara Y; Kimura Y; Fujita J; Imamura H; Kinuta M; Yano M; Hiratsuka M; Kobayashi K; Okada K; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):75-80. PubMed ID: 24155213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of patients with cancer-related genes detected in postoperative peritoneal washings obtained during curative gastrectomy.
    Takebayashi K; Murata S; Kodama H; Kaida S; Yamaguchi T; Ishikawa K; Shimoji M; Miyake T; Ueki T; Kojima M; Iida H; Maehira H; Shimizu T; Tani M
    Eur J Surg Oncol; 2022 Jan; 48(1):177-182. PubMed ID: 34034940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
    Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
    Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
    Ueno H; Yoshida K; Hirai T; Kono F; Kambe M; Toge T
    Anticancer Res; 2003; 23(2C):1701-8. PubMed ID: 12820444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
    Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
    Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery.
    Nakamura K; Iinuma H; Aoyagi Y; Shibuya H; Watanabe T
    Oncology; 2010; 78(5-6):309-15. PubMed ID: 20616575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer.
    Nakanishi K; Kanda M; Umeda S; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Kodera Y
    Gastric Cancer; 2019 Nov; 22(6):1143-1152. PubMed ID: 31055693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.